Ausgabe 3/2022
Inhalt (23 Artikel)
Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
Massimo Breccia
Reviewing Treatment Options for Advanced Renal Cell Carcinoma: Is There Still a Place for Tyrosine Kinase Inhibitor (TKI) Monotherapy?
Mário Fontes-Sousa, Helena Magalhães, Alicia Oliveira, Filipa Carneiro, Filipa Palma dos Reis, Pedro Silvestre Madeira, Sara Meireles
A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab
Lucinda Villaescusa, Francisco Zaragozá, Irene Gayo-Abeleira, Cristina Zaragozá
How to Choose the Right Inhaler Using a Patient-Centric Approach?
Didier Cataldo, Shane Hanon, Rudi V. Peché, Daniel J. Schuermans, Jean M. Degryse, Isabelle A. De Wulf, Karin Elinck, Mathias H. Leys, Peter L. Rummens, Eric Derom
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
Alessia Villani, Luca Potestio, Gabriella Fabbrocini, Massimiliano Scalvenzi
Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review
Juliana M. F. Sallum, Vinay Preet Kaur, Javed Shaikh, Judit Banhazi, Claudio Spera, Celia Aouadj, Daniel Viriato, M. Dominik Fischer
Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs
Charmi Patel, Ahong Huang, Li Wang, Yoshita Paliwal, Kruti Joshi
Real-World Treatment Patterns and Clinical Outcomes for Standard of Care Regimens in Patients with Deficient MMR or MSI-High Metastatic Colorectal and Non-Colorectal Cancer: A Retrospective Chart Review Study in France
Montserrat Roset, Mayur Amonkar, Renna Patel, Núria Lara, Smita Kothari
Biosimilar Pegfilgrastim-cbqv Demonstrated Similar Immunogenicity to Pegfilgrastim in Healthy Subjects Across Three Randomized Clinical Studies
Francesca Civoli, Barbara Finck, Helen Tang, Jennifer Hodge, Hillary O’Kelly, Vladimir Vexler
Management of Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Novel Combination Therapies in Routine Clinical Practice in Germany
H. Tilman Steinmetz, Moushmi Singh, Joseph Milce, Mohamad Haidar, Achim Rieth, Andrea Lebioda, Jörn Kohnke
Hyaluronic Acid Therapy in Hip OA Does Not Perform Equally in Osteoarthritis Secondary to Juvenile Idiopathic Arthritis When Compared to Primary Osteoarthritis: A 2-Year Preliminary Evaluation
Orazio De Lucia, Angela Flavia Luppino, Francesca Pregnolato, Antonella Murgo, Irene Pontikaki, Maurizio Gattinara, Tania Ubiali, Rolando Cimaz, Roberto Caporali
Cost–Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand
Kriengsak Vareesangthip, Chaicharn Deerochanawong, Dittaya Thongsuk, Nuch Pojchaijongdee, Unchalee Permsuwan
Budget Impact Analysis of Impella CP® Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
Clément Delmas, Mathieu Pernot, Alexandre Le Guyader, Romain Joret, Stéphane Roze, Guillaume Lebreton
Early Changes and Predictive Value of Serum Histone H3 Concentration in Urosepsis: A Prospective Observational Study
Xiangcheng Zhan, Ding Liu, Yunze Dong, Yunchen Gao, Xiao Xu, Tiancheng Xie, Hongmin Zhou, Guangchun Wang, Haimin Zhang, Pengfei Wu, Xulin He, Chao Sun, Xudong Yao, Yunfei Xu
Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients in the United States Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines: A Retrospective Cohort Study
Diana T. Amari, Timothy R. Juday, Feride H. Frech, Weiying Wang, Deval Gor, Norman Atkins Jr., Emerson M. Wickwire
Impact of Social Determinants on the Burden of Asthma and Eczema: Results from a US Patient Survey
Don A. Bukstein, Adam Friedman, Erika Gonzalez Reyes, Mary Hart, Bridgette L. Jones, Tonya Winders
Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan
Toru Nakazawa, Kanji Takahashi, Yasuaki Kuwayama, Akio Nomura, Fumiki Shimada
Assessment of the Cost-Effectiveness of HER2-Targeted Treatment Pathways in the Neoadjuvant Treatment of High-Risk HER2-Positive Early-Stage Breast Cancer
Jesse A. Sussell, Joshua A. Roth, Craig S. Meyer, Anita Fung, Svenn A. Hansen
Disease Activity-Guided Stepwise Tapering but Not Discontinuation of Biologics Is a Feasible Therapeutic Strategy for Patients with Ankylosing Spondylitis: Real-World Evidence
Lingying Ye, Ling Zhou, Jianye Bian, Juan Zhao, Ting Li, Xin Wu, Huji Xu
Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
Aki Kato, Tsutomu Yasukawa, Iichiro Sugita, Munenori Yoshida, Miho Nozaki, Yoshio Hirano, Junko Kondo, Tomohiro Abe, Kimiko Sugita, Takahide Okita, Hiroshi Morita, Noriaki Takase, Yuichiro Ogura
iStent inject Trabecular Micro-Bypass with or Without Cataract Surgery Yields Sustained 5-Year Glaucoma Control
Fritz H. Hengerer, Gerd U. Auffarth, Ina Conrad-Hengerer
Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort
Carol Pollock, Glen James, Juan Jose Garcia Sanchez, Matthew Arnold, Juan-Jesus Carrero, Carolyn S. P. Lam, Hungta Chen, Stephen Nolan, Roberto Pecoits-Filho
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study
Maggie Tabberer, C. Elaine Jones, Sally Kilbride, David M. G. Halpin, David A. Lomas, Steven Pascoe, Dave Singh, Robert A. Wise, Gerard J. Criner, Peter Lange, Mark T. Dransfield, MeiLan K. Han, Fernando J. Martinez, Morrys C. Kaisermann, David A. Lipson